On September 14, 2020, the U.S. Food and Drug Administration
(FDA) released an update on the status of its Software
Precertification (Pre-Cert) Program. It is the only public update
on the program in 2020. According to the update, FDA will continue
to evaluate its Pre-Cert program, which currently is only in pilot
form. Perhaps disappointing to many companies, the update did not
suggest that FDA will be adding new participants to the pilot
program at this time, nor did it signal that the program would be
fully operational anytime soon.
Brief Background
The Pre-Cert Program was launched as a pilot program at the end
of 2017 with the participation of nine select
companies. The goal of the program is to develop a streamlined
premarket review process for software as a medical device (SaMD)
that would enable developers to introduce software iterations and
changes under tailored regulatory controls (and without necessarily
submitting a new 510(k) notification). The